Canagliflozin in T1D Has Ketoacidosis Problem (CME/CE)

(MedPage Today) -- SGLT2 inhibitor effective but risky in type 1 patients

Source: MedPage Today Cardiovascular - March 17, 2016 Category: Cardiology Source Type: news